SRIW, Sowalfin, Noshaq and CCF (Centre de Cautionnement et de Financement du Valais) are now part of the AARDEX Adventure.
Breaking News
Dose reduction’s role in tackling Pharma 2.0’s profitability problem
The economic model that has underpinned the development of drug products for decades is currently under siege. Faced on one side with mounting pressure from payers to address affordability issues, pharmaceutical companies are facing ever more stringent regulatory requirements alongside